| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 2.60 | Low level resistance | Recombinant | Details | Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing. (Aug 2014) | ||
| Cidofovir | 1.70 | No resistance | Recombinant | Details | Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing. (Aug 2014) | ||
| Foscarnet | 6.30 | High level resistance | Recombinant | Details | Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing. (Aug 2014) | ||
| Foscarnet | 3.60 | Intermediate level resistance | Clinical Isolate | Details | Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene. (Feb 2017) | ||
| Foscarnet | 4.40 | Intermediate level resistance | Clinical Isolate | Details | Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene. (Feb 2017) |